HYMPAVZI
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for HYMPAVZI, covering 2024-10-11 to 2026-07-16. Get the full timeline:
Most recent: EMA Authorised: Hympavzi (marstacimab) — Pfizer Europe MA EEIG
6 regulatory and trial events tracked for HYMPAVZI, covering 2024-10-11 to 2026-07-16. Get the full timeline:
Most recent: EMA Authorised: Hympavzi (marstacimab) — Pfizer Europe MA EEIG